| Trial ID: | L3476 |
| Source ID: | NCT00478322
|
| Associated Drug: |
Placebo
|
| Title: |
Pharmacodynamic Study of the Effect of INCB013739 on Insulin Sensitivity in Obese, Type 2 Diabetic Subjects
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2|Obesity
|
| Interventions: |
DRUG: Placebo|DRUG: INCB013739
|
| Outcome Measures: |
Primary: Changes in lipid profile laboratory values, Measured at baseline and weekly for four weeks|Assessment of pharmacokinetics of INCB013739 through analysis of blood samples., Measured at baseline and weekly for four weeks|Assessment of pharmacodynamics of INCB013739 through analysis of blood samples, Measured at baseline and weekly for four weeks|Assessment of ECGs, physical examinations and laboratory values for adverse events, Measured at baseline through study completion |
|
| Sponsor/Collaborators: |
Sponsor: Incyte Corporation
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
24
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2007-04
|
| Completion Date: |
2008-02
|
| Results First Posted: |
|
| Last Update Posted: |
2016-12-06
|
| Locations: |
Chula Vista, California, 91911, United States|Bronx, New York, 10461, United States|San Antonio, Texas, 78229, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00478322
|
